Achieve Life Sciences Balance Sheet Health
Financial Health criteria checks 4/6
Achieve Life Sciences has a total shareholder equity of $31.4M and total debt of $9.8M, which brings its debt-to-equity ratio to 31.3%. Its total assets and total liabilities are $47.9M and $16.5M respectively.
Key information
31.3%
Debt to equity ratio
US$9.82m
Debt
Interest coverage ratio | n/a |
Cash | US$42.91m |
Equity | US$31.38m |
Total liabilities | US$16.54m |
Total assets | US$47.92m |
Recent financial health updates
Does Achieve Life Sciences (NASDAQ:ACHV) Have A Healthy Balance Sheet?
Jan 27Is Achieve Life Sciences (NASDAQ:ACHV) Using Debt In A Risky Way?
Oct 26Is Achieve Life Sciences (NASDAQ:ACHV) A Risky Investment?
Mar 26Is Achieve Life Sciences (NASDAQ:ACHV) Weighed On By Its Debt Load?
Mar 22Is Achieve Life Sciences (NASDAQ:ACHV) In A Good Position To Deliver On Growth Plans?
Sep 27Recent updates
Achieve Life Sciences: 1st Half 2025 NDA Filing On Track With FDA Agreement
Jul 01Does Achieve Life Sciences (NASDAQ:ACHV) Have A Healthy Balance Sheet?
Jan 27Is Achieve Life Sciences (NASDAQ:ACHV) Using Debt In A Risky Way?
Oct 26Is Achieve Life Sciences (NASDAQ:ACHV) A Risky Investment?
Mar 26Achieve Life Sciences begins phase 2 trial testing cytisinicline for nicotine e-cigarette cessation
Jun 29Achieve Life Sciences: Initiating Buy, Potential Multi-Billion-Dollar Smoking Cessation Drug
Apr 04Is Achieve Life Sciences (NASDAQ:ACHV) Weighed On By Its Debt Load?
Mar 22Is Achieve Life Sciences (NASDAQ:ACHV) In A Good Position To Deliver On Growth Plans?
Sep 27We Think Achieve Life Sciences (NASDAQ:ACHV) Needs To Drive Business Growth Carefully
Jun 14We're Keeping An Eye On Achieve Life Sciences' (NASDAQ:ACHV) Cash Burn Rate
Mar 01Achieve Life Sciences prices stock offering at $7; shares down 2%
Dec 03Achieve Life Sciences launches equity offering
Nov 30Financial Position Analysis
Short Term Liabilities: ACHV's short term assets ($45.5M) exceed its short term liabilities ($6.7M).
Long Term Liabilities: ACHV's short term assets ($45.5M) exceed its long term liabilities ($9.8M).
Debt to Equity History and Analysis
Debt Level: ACHV has more cash than its total debt.
Reducing Debt: ACHV's debt to equity ratio has increased from 0% to 31.3% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ACHV has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: ACHV has less than a year of cash runway if free cash flow continues to reduce at historical rates of 15.7% each year
Discover healthy companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/05 02:32 |
End of Day Share Price | 2025/01/03 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Achieve Life Sciences, Inc. is covered by 10 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
null null | CG Capital |
Gary Nachman | CGS International |
Ilya Zubkov | Freedom Broker |